Crunching the numbers for CC... Refresh in a moment for the full analysis.
Chemours Co (CC)
Healthcare
mixed
$22.71
Updated: 2026-04-12
Financial Strength
45
Mixed
Operating Trend
60
Healthy
Capital Allocation
55
Mixed
Key Findings
+
Strong FCF growth — free cash flow up more than 20% year over year
−
Piotroski F-Score 0–3 — multiple financial weakness signals
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.